Japan's TISI backs Taiwan's FaceHeart, maker of FDA-cleared camera vitals tech
What's the deal? TISIDealroom has a profile for this one. Try Dealroom →, a Japanese IT services company in the TIS Intec Group, has invested in FaceHeartDealroom has a profile for this one. Try Dealroom →, a Taipei-based digital health startup that uses AI to measure vital signs from ordinary camera footage of a person's face. The deal was announced on November 6, 2026. Neither company disclosed the size of the investment.
What does FaceHeart do? Its technology, called remote photoplethysmography (rPPG), reads data such as heart rate and respiratory rate from facial video without wearables or sensors. The company says its heart-rate and respiratory-rate measurements hold US Food and Drug Administration 510(k) clearances. Its flagship products are the FaceHeart Vitals SDK and CardioMirror, an AI-powered smart mirror that won a CES 2025 Innovation Award in the Digital Health category.
Why now? TISIDealroom has a profile for this one. Try Dealroom → points to rising Japanese demand for preventive medicine and routine health monitoring, driven by an ageing population, climbing medical costs, and a shortage of healthcare workers. The startup's software-development-kit format makes the technology easy to embed into existing apps and devices.
What's the endgame? TISI said it will help FaceHeart expand in Japan and explore joint work across preventive medicine, corporate wellness, elderly and nursing-care facilities, and offices. As a first step, it has installed CardioMirror at its head office and Toyosu office to measure visitors' heart rate and blood pressure, with testing starting November 6.
What could go wrong? The technology's broader clinical promise is unsettled. Recent research stresses the need to validate contactless monitoring across real-world conditions and diverse patient groups, particularly for measurements beyond basic heart rate. Commercial payoff will hinge on deployment and further validation, not the measurement claim alone.
The signal: Interest in contactless vital-sign monitoring is growing. Saudi Arabia's regulator authorised an rPPG-based app in June 2026 to measure heart rate, oxygen saturation, and blood pressure, with calibration required for blood pressure. For TISI, which serves more than 4,500 clients, FaceHeart offers a regulatory foothold to extend its healthcare business — if the technology proves itself at scale.
Read more: prtimes.jp
Image credit: NavyMedicine
